Isoform-selective TGF-β3 inhibition for systemic sclerosis. - Sun T; Vander Heiden JA; Gao X; Yin J; Uttarwar S; Liang WC; Jia G; Yadav R; Huang Z; Mitra M; Halpern W; Bender HS; et al. (Med (New York, N.Y.), 2024)